As part of its 2021 training series, SFL will host an accredited virtual training course on ‘Strategic regulatory considerations for global drug development’ on 16 December 2021, 3-6 pm CET.

This training will provide an introduction to the global drug development process, with a specific focus on Europe and the US. SFL regulatory experts will share their insights on the role of regulatory affairs and opportunities and challenges for the development of medicines and pathways for marketing approval.

The training will be led by Anja Bührer, Head Global Regulatory Affairs, Julien Gaudias, Head EU Regulatory Affairs, Robin Conrad, Senior Consultant US Regulatory Affairs and Ben Stockham, Senior Consultant Global Regulatory Affairs at SFL.

Participants in the training will be awarded 3 SwAPP credits.

You can register now via this link.